-
1
-
-
78649375771
-
Neutrophils, from marrow to microbes
-
Borregaard, N. Neutrophils, from marrow to microbes. Immunity 2010, 33, 657-70.
-
(2010)
Immunity
, vol.33
, pp. 657-670
-
-
Borregaard, N.1
-
2
-
-
79952213893
-
The paradox of the neutrophil's role in tissue injury
-
Segel, G.B.; Halterman, M.W.; Lichtman, M.A. The paradox of the neutrophil's role in tissue injury. J. Leukoc. Biol. 2011, 89, 359-372.
-
(2011)
J. Leukoc. Biol.
, vol.89
, pp. 359-372
-
-
Segel, G.B.1
Halterman, M.W.2
Lichtman, M.A.3
-
3
-
-
33745617094
-
Neutrophils in development of multiple organ failure in sepsis
-
Brown, K.A.; Brain, S.D.; Pearson, J.D.; Edgeworth, J.D.; Lewis, S.M.; Treacher, D.F. Neutrophils in development of multiple organ failure in sepsis. Lancet 2006, 368, 157-169.
-
(2006)
Lancet
, vol.368
, pp. 157-169
-
-
Brown, K.A.1
Brain, S.D.2
Pearson, J.D.3
Edgeworth, J.D.4
Lewis, S.M.5
Treacher, D.F.6
-
4
-
-
33344468233
-
Neutrophils and immunity: Challenges and opportunities
-
Nathan, C. Neutrophils and immunity: Challenges and opportunities. Nat. Rev. Immunol. 2006, 6, 173-182.
-
(2006)
Nat. Rev. Immunol.
, vol.6
, pp. 173-182
-
-
Nathan, C.1
-
5
-
-
0036839229
-
Formyl-peptide receptors revisited
-
Le, Y.; Murphy, P.M.; Wang, J.M. Formyl-peptide receptors revisited. Trends Immunol. 2002, 23, 541-548.
-
(2002)
Trends Immunol.
, vol.23
, pp. 541-548
-
-
Le, Y.1
Murphy, P.M.2
Wang, J.M.3
-
6
-
-
0020062002
-
Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils
-
Carp, H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 1982, 155, 264-275.
-
(1982)
J. Exp. Med.
, vol.155
, pp. 264-275
-
-
Carp, H.1
-
7
-
-
0021333230
-
Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli
-
Marasco, W.A.; Phan, S.H.; Krutzsch, H.; Showell, H.J.; Feltner, D.E.; Nairn, R.; Becker, E.L.; Ward, P.A. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 1984, 259, 5430-5439.
-
(1984)
J. Biol. Chem.
, vol.259
, pp. 5430-5439
-
-
Marasco, W.A.1
Phan, S.H.2
Krutzsch, H.3
Showell, H.J.4
Feltner, D.E.5
Nairn, R.6
Becker, E.L.7
Ward, P.A.8
-
8
-
-
77953788926
-
Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1
-
discussion 1332-1334
-
Raoof, M.; Zhang, Q.; Itagaki, K.; Hauser, C.J. Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1. J. Trauma 2010, 68, 1328-1332; discussion 1332-1334.
-
(2010)
J. Trauma
, vol.68
, pp. 1328-1332
-
-
Raoof, M.1
Zhang, Q.2
Itagaki, K.3
Hauser, C.J.4
-
9
-
-
77950275298
-
Circulating mitochondrial DAMPs cause inflammatory responses to injury
-
Zhang, Q.; Raoof, M.; Chen, Y.; Sumi, Y.; Sursal, T.; Junger, W.; Brohi, K.; Itagaki, K.; Hauser, C.J. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464, 104-107.
-
(2010)
Nature
, vol.464
, pp. 104-107
-
-
Zhang, Q.1
Raoof, M.2
Chen, Y.3
Sumi, Y.4
Sursal, T.5
Junger, W.6
Brohi, K.7
Itagaki, K.8
Hauser, C.J.9
-
10
-
-
77954218503
-
Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists
-
Dufton, N.; Perretti, M. Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists. Pharmacol. Ther. 2010, 127, 175-188.
-
(2010)
Pharmacol. Ther.
, vol.127
, pp. 175-188
-
-
Dufton, N.1
Perretti, M.2
-
11
-
-
67349092463
-
Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; Affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action
-
Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Hamann, M.T. Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochim. Biophys. Acta 2009, 1790, 283-308.
-
(2009)
Biochim. Biophys. Acta
, vol.1790
, pp. 283-308
-
-
Mayer, A.M.1
Rodriguez, A.D.2
Berlinck, R.G.3
Hamann, M.T.4
-
12
-
-
34247109045
-
Natural products as sources of new drugs over the last 25 years
-
Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod .2007, 70, 461-477.
-
(2007)
J. Nat. Prod.
, vol.70
, pp. 461-477
-
-
Newman, D.J.1
Cragg, G.M.2
-
13
-
-
58149189779
-
Drug development from marine natural products
-
Molinski, T.F.; Dalisay, D.S.; Lievens, S.L.; Saludes, J.P. Drug development from marine natural products. Nat. Rev. Drug Discov. 2009, 8, 69-85.
-
(2009)
Nat. Rev. Drug Discov.
, vol.8
, pp. 69-85
-
-
Molinski, T.F.1
Dalisay, D.S.2
Lievens, S.L.3
Saludes, J.P.4
-
14
-
-
79952827479
-
Contribution of neutrophils to acute lung injury
-
Grommes, J.; Soehnlein, O. Contribution of neutrophils to acute lung injury. Mol. Med. 2011, 17, 293-307.
-
(2011)
Mol. Med.
, vol.17
, pp. 293-307
-
-
Grommes, J.1
Soehnlein, O.2
-
15
-
-
79956152545
-
2-(2- Fluorobenzamido)benzoate ethyl ester (EFB-1) inhibits superoxide production by human neutrophils and attenuates hemorrhagic shock-induced organ dysfunction in rats
-
Yu, H.P.; Hsieh, P.W.; Chang, Y.J.; Chung, P.J.; Kuo, L.M.; Hwang, T.L. 2-(2- Fluorobenzamido)benzoate ethyl ester (EFB-1) inhibits superoxide production by human neutrophils and attenuates hemorrhagic shock-induced organ dysfunction in rats. Free Radic. Biol. Med. 2011, 50, 1737-1748.
-
(2011)
Free Radic. Biol. Med.
, vol.50
, pp. 1737-1748
-
-
Yu, H.P.1
Hsieh, P.W.2
Chang, Y.J.3
Chung, P.J.4
Kuo, L.M.5
Hwang, T.L.6
-
16
-
-
48649087006
-
Cyclic AMP: Master regulator of innate immune cell function
-
Serezani, C.H.; Ballinger, M.N.; Aronoff, D.M.; Peters-Golden, M. Cyclic AMP: Master regulator of innate immune cell function. Am. J. Respir. Cell Mol. Biol. 2008, 39, 127-132.
-
(2008)
Am. J. Respir. Cell Mol. Biol.
, vol.39
, pp. 127-132
-
-
Serezani, C.H.1
Ballinger, M.N.2
Aronoff, D.M.3
Peters-Golden, M.4
-
17
-
-
77954681058
-
The role of calcium signaling in phagocytosis
-
Nunes, P.; Demaurex, N. The role of calcium signaling in phagocytosis. J. Leukoc. Biol. 2010, 88, 57-68.
-
(2010)
J. Leukoc. Biol.
, vol.88
, pp. 57-68
-
-
Nunes, P.1
Demaurex, N.2
-
18
-
-
33644882726
-
Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils
-
Selvatici, R.; Falzarano, S.; Mollica, A.; Spisani, S. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur. J. Pharmacol. 2006, 534, 1-11.
-
(2006)
Eur. J. Pharmacol.
, vol.534
, pp. 1-11
-
-
Selvatici, R.1
Falzarano, S.2
Mollica, A.3
Spisani, S.4
-
19
-
-
84871875351
-
Potent inhibition of human neutrophil activations by bractelactone, a novel chalcone from Fissistigma bracteolatum
-
Wu, Y.C.; Sureshbabu, M.; Fang, Y.C.; Wu, Y.H.; Lan, Y.H.; Chang, F.R.; Chang, Y.W.; Hwang, T.L. Potent inhibition of human neutrophil activations by bractelactone, a novel chalcone from Fissistigma bracteolatum. Toxicol. Appl. Pharmacol. 2013, 266, 399-407.
-
(2013)
Toxicol. Appl. Pharmacol.
, vol.266
, pp. 399-407
-
-
Wu, Y.C.1
Sureshbabu, M.2
Fang, Y.C.3
Wu, Y.H.4
Lan, Y.H.5
Chang, F.R.6
Chang, Y.W.7
Hwang, T.L.8
-
20
-
-
84879121228
-
Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1
-
in press
-
Yang, S.C.; Chung, P.J.; Ho, C.M.; Kuo, C.Y.; Hung, M.F.; Huang, Y.T.; Chang, W.Y.; Chang, Y.W.; Chan, K.H.; Hwang, T.L. Propofol Inhibits Superoxide Production, Elastase Release, and Chemotaxis in Formyl Peptide-Activated Human Neutrophils by Blocking Formyl Peptide Receptor 1. J. Immunol. 2013, in press.
-
(2013)
J. Immunol.
-
-
Yang, S.C.1
Chung, P.J.2
Ho, C.M.3
Kuo, C.Y.4
Hung, M.F.5
Huang, Y.T.6
Chang, W.Y.7
Chang, Y.W.8
Chan, K.H.9
Hwang, T.L.10
-
21
-
-
20444488858
-
Culturable marine actinomycete diversity from tropical Pacific Ocean sediments
-
Jensen, P.R.; Gontang, E.; Mafnas, C.; Mincer, T.J.; Fenical, W. Culturable marine actinomycete diversity from tropical Pacific Ocean sediments. Environ. Microbiol. 2005, 7, 1039-1048.
-
(2005)
Environ. Microbiol.
, vol.7
, pp. 1039-1048
-
-
Jensen, P.R.1
Gontang, E.2
Mafnas, C.3
Mincer, T.J.4
Fenical, W.5
-
22
-
-
0346366927
-
Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway
-
Hwang, T.L.; Hung, H.W.; Kao, S.H.; Teng, C.M.; Wu, C.C.; Cheng, S.J. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway. Mol. Pharmacol. 2003, 64, 1419-1427.
-
(2003)
Mol. Pharmacol.
, vol.64
, pp. 1419-1427
-
-
Hwang, T.L.1
Hung, H.W.2
Kao, S.H.3
Teng, C.M.4
Wu, C.C.5
Cheng, S.J.6
-
23
-
-
34548041876
-
The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1
-
Stenfeldt, A.L.; Karlsson, J.; Wenneras, C.; Bylund, J.; Fu, H.; Dahlgren, C. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1. Biochem. Pharmacol. 2007, 74, 1050-1056.
-
(2007)
Biochem. Pharmacol.
, vol.74
, pp. 1050-1056
-
-
Stenfeldt, A.L.1
Karlsson, J.2
Wenneras, C.3
Bylund, J.4
Fu, H.5
Dahlgren, C.6
-
24
-
-
77956229778
-
The hederagenin saponin SMG-1 is a natural FMLP receptor inhibitor that suppresses human neutrophil activation
-
Hwang, T.L.; Wang, C.C.; Kuo, Y.H.; Huang, H.C.; Wu, Y.C.; Kuo, L.M.; Wu, Y.H. The hederagenin saponin SMG-1 is a natural FMLP receptor inhibitor that suppresses human neutrophil activation. Biochem. Pharmacol. 2010, 80, 1190-1200.
-
(2010)
Biochem. Pharmacol.
, vol.80
, pp. 1190-1200
-
-
Hwang, T.L.1
Wang, C.C.2
Kuo, Y.H.3
Huang, H.C.4
Wu, Y.C.5
Kuo, L.M.6
Wu, Y.H.7
-
25
-
-
77953684206
-
Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury?
-
Gavins, F.N. Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury? Trends Pharmacol. Sci. 2010, 31, 266-276.
-
(2010)
Trends Pharmacol. Sci.
, vol.31
, pp. 266-276
-
-
Gavins, F.N.1
|